ROSINI, Sandra
 Distribuzione geografica
Continente #
NA - Nord America 4.834
EU - Europa 3.657
AS - Asia 2.847
Continente sconosciuto - Info sul continente non disponibili 389
SA - Sud America 325
AF - Africa 51
OC - Oceania 7
Totale 12.110
Nazione #
US - Stati Uniti d'America 4.736
SG - Singapore 1.085
RU - Federazione Russa 923
CN - Cina 875
UA - Ucraina 522
IT - Italia 452
IE - Irlanda 399
GB - Regno Unito 379
SE - Svezia 367
TR - Turchia 327
VN - Vietnam 262
BR - Brasile 261
FR - Francia 204
DE - Germania 200
IN - India 132
FI - Finlandia 104
CA - Canada 60
BD - Bangladesh 38
AR - Argentina 28
HK - Hong Kong 26
ZA - Sudafrica 24
PL - Polonia 22
MX - Messico 21
CZ - Repubblica Ceca 20
IQ - Iraq 19
BE - Belgio 13
ES - Italia 12
NL - Olanda 12
EC - Ecuador 11
JP - Giappone 10
KR - Corea 9
CO - Colombia 8
EU - Europa 8
ID - Indonesia 7
MA - Marocco 7
PK - Pakistan 7
AT - Austria 6
GR - Grecia 6
JM - Giamaica 6
JO - Giordania 6
SA - Arabia Saudita 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
CL - Cile 5
MY - Malesia 5
VE - Venezuela 5
IL - Israele 4
KE - Kenya 4
LT - Lituania 4
TN - Tunisia 4
CR - Costa Rica 3
EG - Egitto 3
OM - Oman 3
AO - Angola 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BY - Bielorussia 2
CH - Svizzera 2
DK - Danimarca 2
IR - Iran 2
NZ - Nuova Zelanda 2
PE - Perù 2
PY - Paraguay 2
UG - Uganda 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AM - Armenia 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BZ - Belize 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GD - Grenada 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MW - Malawi 1
NG - Nigeria 1
NI - Nicaragua 1
NP - Nepal 1
PA - Panama 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
TC - Turks e Caicos 1
TH - Thailandia 1
Totale 11.731
Città #
Singapore 756
Jacksonville 543
San Jose 516
Chandler 496
Dallas 443
Dublin 393
Southend 289
Dearborn 283
Ashburn 241
Council Bluffs 213
Beijing 195
Izmir 188
Princeton 186
Nanjing 160
Wilmington 104
Cambridge 93
The Dalles 93
Los Angeles 84
Ho Chi Minh City 79
Tongling 76
Chieti 68
Ann Arbor 65
Nanchang 62
Santa Clara 62
Buffalo 61
New York 60
Boardman 59
Hanoi 54
Dong Ket 43
Woodbridge 41
Shenyang 36
Munich 35
Altamura 34
Moscow 34
Columbus 32
Rome 29
Recife 28
Hebei 27
Redondo Beach 26
Kunming 25
Toronto 24
Hefei 23
San Mateo 23
São Paulo 23
Grevenbroich 22
Milan 20
Tianjin 20
Warsaw 20
Changsha 19
Brno 18
Hong Kong 17
London 17
Norwalk 17
Chennai 16
Jinan 16
Orem 15
Phoenix 15
Chicago 14
Hangzhou 14
Houston 14
Jiaxing 14
Ankara 13
Johannesburg 13
Augusta 12
Denver 12
Montreal 12
Washington 12
Boston 11
Brooklyn 11
Brussels 11
Frankfurt am Main 11
San Francisco 11
Atlanta 10
Teramo 10
Tokyo 10
Haiphong 9
Helsinki 9
Seoul 9
Vasto 9
Da Nang 8
Leawood 8
Mumbai 8
Nuremberg 8
Pescara 8
Turku 8
Falls Church 7
Francavilla Al Mare 7
Guangzhou 7
Kocaeli 7
Montesilvano 7
Ningbo 7
Ninh Bình 7
Amman 6
Auburn Hills 6
Baghdad 6
Belo Horizonte 6
Buenos Aires 6
Campinas 6
Porto San Giorgio 6
Quito 6
Totale 7.033
Nome #
1,2-Dimethylhydrazine-induced colon carcinoma and lymphoma in msh2(-/-) mice. 1.264
Effective assessment of egfr mutation status in bronchoalveolar lavage and pleural fluids by next-generation sequencing. 179
Thin Prep Gel-Based Proteomics Approach: New Methodology to Give Protein Signature in Residual Cervical Cytology Samples 176
Complementary reactivities of anti-carcinoembryonic antigen and antitumor-associated glycoprotein 72 monoclonal antibodies in lung carcinomas. 168
Diagnostica molecolare delle infezioni da HPV nelle neoformazioni del cavo orale- orofaringe. Dati preliminari sulla ricerca della integrazione del genoma virale 168
HPV e displasie della cervice uterina: ricerca dell'HPV-DNA con PCR e correlazioni con l'esame citologico, colposcopico e istobioptico 164
Analytic and Diagnostic Performances of Human Papillomavirus E6/E7 mRNA Test on up-to 11-Year-Old Liquid-Based Cervical Samples. A Biobank-Based Longitudinal Study 164
Interleukin 1alpha and interleukin 6 promote the in vitro growth of both normal and neoplastic human cervical epithelial cells. 162
Chromogenic In Situ Hybridization and p16/Ki67 Dual Staining on Formalin-Fixed Paraffin-Embedded Cervical Specimens: Correlation with HPV-DNA Test, E6/E7 mRNA Test, and Potential Clinical Applications. 162
Role of E6/E7 mRNA test in the diagnostic algorithm of HPV-positive patients showing ASCUS and LSIL: clinical and economic implications in a publicly financed healthcare system 162
In vivo studies of cytokines and growth factors involved in inflammation by using engineered tumor cells as biological minipumps. 154
The expression of LEC/CCL16, a powerful inflammatory chemokine, is upregulated in ulcerative colitis. 153
HPV mRNA test and p16/Ki67 dual-stain cytology: which is the best option to improve HPV DNA-based screening programs? 152
Distribution and phenotype of immune cells in normal human gingiva: active immune response versus unresponsiveness. 148
Implementing specificity of HPV-DNA primary screening in a successful organised cervical cancer prevention programme. 146
Depletion of stromal and intraepithelial antigen-presenting cells in vervical neoplasia in human immunodificiency virus infection 145
Detection of Helicobacter pylori by PCR on gastric biopsy specimens taken for CP test: comparison with histopathological analysis. 144
GISTs: from the history to the tailored therapy 144
A very rare case of HPV 53-related cervical cancer, in a 79-years old women with a previous history of negative Pap cytology 144
Expression of PTEN in endometrial liquid-based cytology 144
E6/E7 mRNA test in ASCUS and LSIL triage: economic implications in a publicly financed health care system. 143
Mutational analysis of the HER2 gene in lung tumors from Caucasian patients: mutations are mainly present in adenocarcinomas with bronchioloalveolar features. 142
IL-12 can target human lung adenocarcinoma cells and normal bronchial epithelial cells surrounding tumor lesions. 142
Int6 expression can predict survival in early-stage non-small cell lung cancer patients. 141
Ricerca con PCR e genotipizzazione dell'HPVDNA in donne con dispiasia della cervice uterina e nei loro partner 140
HPV model: from gender medicine to healthcare of the couple. 140
A case of recurrent laryngeal papillomatosis HPV-6 and -18 related 137
Detection of nuclear and membrane antigens by liquid-based cytology following long-term storage of d1 cells, karpas cells, and peripheral blood mononuclear cells. 134
Prognostic value of HPV E6/E7 mRNA assay in women with negative colposcopy or CIN1 histology result: a follow-up study 134
Cellule immunocompetenti associate alla mucosa nella patologia della cervice uterina dei soggetti HIV-infetti 133
Overview on molecular markers to improve cervical cancer prevention: challenges and perspectives 132
Solitary plasmacytoma of the tonsillar site associated with actinomyces infection: the possible role of IL-6. 132
Thin-layer cytopathology of a gastrointestinal stromal tumor (GIST) in effusion: diagnostic dilemmas. 131
Cervical cancer screening: from molecular basis to diagnostic practice, going through new technologies. 130
Human papillomavirus warts in childhood. Diagnostic and medico-legal considerations. 129
Is HPV-DNA testing a useful tool in predicting low-grade squamous intraepithelial lesion outcome? A retrospective longitudinal study. 127
UTILIZATION OF LIQUID BASED CYTOLOGY IN IN VITRO EXPERIMENTAL ANALYSES 126
Analytic and diagnostic performances of HPV E6/E7 mRNA test on up-to 11-year-old liquid-based cervical samples: a retrospective longitudinal study 125
Detection of Residual/Recurrent Cervical Disease after Successful LEEP Conization: the Possible Role of mRNA-HPV Test 124
Management and triage of women in follow-up for low-grade cervical disease: association of DNA and RNA-Based methods 123
Proinflammatory cytokines IL1 and IL6 are autocrine and/or paracrine growth factors for normal and neoplastic epithelial cells from human uterine cervix. 123
Sensitivity, specificity, and clinical value of human papillomavirus (HPV) E6/E7 mRNA assay as a triage test for cervical cytology and HPV DNA test. 122
Comparison of oncogenic HPV type-specific viral load and E6/E7 mRNA detection in cervical samples: results from a Multicenter study. 121
CX3CL1/Fractalkine expression by antigen presenting cells and endothelial cells leads to NK cell recruitment in human cardiac allograft rejection. 120
Looking for the most efficacious device to collect oro-pharyngeal cells for morphological and molecular purposes 120
The lack of epithelial interleukin-7 and BAFF/BLyS gene expression in prostate cancer as a possible mechanism of tumor escape from immunosurveillance. 117
L'angiogenesi e le alterazioni vascolari giocano un ruolo cruciale nel promuovere o inibire la crescita tumorale di un adenocarcinoma mammario murino ingegnerizzato con i geni di IL5 o di IL4. 116
Immunopathological alterations of the prostate-associated lymphoid tissue (PALT) by androgen ablation in patients with prostate cancer 115
Immune cell characterization and cytokine detection in inflammatory bowel disease. 113
Valutazione dell’espressione delle oncoproteine di Papillomavirus nella gestione e nel triage delle donne in follow-up per lesioni di basso grado. 113
The prostate-associated lymphoid tissue (PALT) is heavily compromised in prostate cancer but differently altered depending on androgen ablation. 110
Limiti della peniscopia nell’individuazione dell’infezione da HPV nei partner maschili di donne con lesioni cervicali HPV associate 110
Negativizzazione dell’HPV test dopo sei mesi di uso del condom in maschi con infezione peniena da HPV 109
Intraepithelial immune cells in normal uterine cervix and HPV-associated diseases. 105
L'INTERLEUCHINA 7 INDUCE MIELOPOIESI ED ERITROPOIESI: RUOLO DEI LINFOCITI T 105
Building sustainable capacity for disease diagnosis in sub-Saharan Africa: case studies of cooperation in diagnostic pathology. 105
Determinazione immunocitochimica di p16 INK4a per la caratterizzazione delle lesioni cervicali positive per Papillomavirus ad alto rischio oncogeno 104
Detection of gene mutations on cytological specimens: clinical implications 102
Network of immunoregolatory cell subsets and mediators involved in human cardiac allograft rejection. 102
Human papillomavirus (HPV) oncogene expression improves management and triage of women in follow-up for low-grade cervical disease. 102
Associazione HPV-DNA test/p16 INK4a per il monitoraggio ed il trattamento delle lesioni cervicali pre-neoplastiche 99
Carcinosarcoma endometriale: diagnosi citologica su strato sottile 99
Introduzione dell’mRNA test nell’algoritmo diagnostico delle lesioni cervicali di basso grado: benefici, implicazioni prognostiche ed analisi costo-efficacia. 97
Progression marker in gynecologic cervical cytology 97
Presenza di HPV ad alto rischio oncogeno esclusivamente nel partner maschile di donne con infezione da HPV a basso rischio 97
The Lack of IL-12Rbeta2 signaling in lung adenocarcinomas is a novel mechanism of tumor escape from immune surveillance 95
Valutazione dell’espressione delle oncoproteine del Papillomavirus nella gestione e nel triage delle donne in follow-up per lesioni di basso grado 94
The significance of mRNA testing in the follow-up period after successful LEEP conisation 94
Cytologic versus virologic analyses of specimens collected from different genital area in asymptomatic male population 93
HPV-DNA test: strumento utile nella valutazione prognostica delle lesioni di basso grado? 91
Human papillomavirus (HPV) oncogene expression improves management and triage of women in follow-up for low-grade cervical disease 89
Molecular biology update on low-grade cervical lesions in young women 89
p16/Ki67 dual-stain cytology as a reflex test within HPV DNA-based screening program 89
Immune cells in periapical granuloma: morphological and immunohistochemical characterization. 88
Stabilita’ del dna in campioni citologici conservati in fase liquida 88
p16INK4a improves the screening of cervical cancer 87
Metodiche a DNA e ad RNA nel follow-up delle lesioni HPV-indotte 87
Su un raro caso di carcinoma duttale intracistico della mammella. 87
Indagini molecolari nella valutazione della cupola vaginale 86
null 85
Tumore stromale gastrointestinale (GIST): raro caso di diagnosi citologica su versamento 85
Immunocitochimica con Galectina-3 quale strumento in grado di perfezionare la diagnosi citologica preoperatoria delle lesioni nodulari tiroidee 84
Is HPV-DNA Testing a Useful Tool in Predicting ASC-US/LSIL Outcome? 84
Timoma corticale-midollare misto: diagnosi citologica. 84
Langerhans cells in Langerhans cell histiocytosis and peripheral adenocarcinomas of the lung. 83
Uterine Sarcomas: An Updated Overview 77
“Determinazione immunocitochimica di p16 INK4a per la caratterizzazione delle lesioni cervicali positive per Papillomavirus ad alto rischio oncogeno 77
Galectina-3 nella valutazione pre-operatoria dei noduli tiroidei: citologia convenzionale vs citologia su strato sottile 76
Management and triage of women in follow-up for low-grade cervical disease: association of DNA and RNA-based methods. 76
Management and triage of women in follow-up for low-grade cervical disease: association of DNA and RNA-based methods 73
New Technologies in Vaginal Vault Examination 73
Le nuove tecnologie applicate al follow-up delle pazienti isterectomizzate 71
Human papillomavirus (HPV) oncogene expression improves management and triage of women in follow-up for low-grade cervical disease. 70
Primary lymph node infarct and malignant non Hodgkin's lymphoma. Description of a case 64
Uterine Sarcomas: An Updated Overview. Part 1: Smooth Muscle Tumors 60
Totale 12.110
Categoria #
all - tutte 43.962
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.962


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022413 0 0 9 95 63 9 8 34 25 19 47 104
2022/20231.309 107 157 78 154 128 286 74 102 148 23 27 25
2023/2024557 45 22 32 10 32 134 156 26 13 13 7 67
2024/20251.442 93 213 192 63 38 25 9 71 169 62 186 321
2025/20264.026 264 178 541 340 276 209 542 234 936 252 180 74
2026/2027278 56 191 31 0 0 0 0 0 0 0 0 0
Totale 12.110